This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Zanamivir

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: ===Pharmacokinetics=== {| class="wikitable" border="1" width="52%" style="text-align:center" |- ! colspan="12" align="center"| HIV Protease Inhibitor [[Pharmaceutical_Drugs#Pharmacokineti...)
Line 2: Line 2:
{| class="wikitable" border="1" width="52%" style="text-align:center"
{| class="wikitable" border="1" width="52%" style="text-align:center"
|-
|-
-
! colspan="12" align="center"| HIV Protease Inhibitor [[Pharmaceutical_Drugs#Pharmacokinetics_Translated|Pharmacokinetics]]<ref>PMID:20400409</ref><ref>Ferry et al, United States Patent US6147095, Pharmacia & Upjohn Company.</ref><ref>L. Veronese et al. Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects with Normal or Impaired Hepatic Function. Antimicrob Agents Chemother. 2000 April; 44(4): 821–826.</ref><ref>J. Ford, et al. Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected Patients. Antimicrob Agents Chemother. 2004 July; 48(7): 2388–2393.</ref><ref>PMID:10620574</ref><ref>PMID:16086644</ref><ref>PMID:19131522</ref><ref>PMID: 10952482</ref><ref>PMID:16338276</ref><ref>PMID:19729375</ref><ref>PMID:12668574</ref><ref>PMID:17255144</ref><ref>PMID:10858338</ref>
+
! colspan="12" align="center"| Neuraminidase Inhibitor [[Pharmaceutical_Drugs#Pharmacokinetics_Translated|Pharmacokinetics]]
|-
|-
! Parameter
! Parameter

Revision as of 14:55, 8 December 2010

Pharmacokinetics

Neuraminidase Inhibitor Pharmacokinetics
Parameter Ritonavir Oseltamivir
Tmax (hr) Ritonavir Oseltamivir
Cmax (ng/ml) Ritonavir Oseltamivir
Bioavailability (%) Ritonavir Oseltamivir
Protein Binding (%) Ritonavir Oseltamivir
T1/2 (hr) Ritonavir Oseltamivir
AUC (ng/ml/hr) Ritonavir Oseltamivir
Clearance (L/h) Ritonavir Oseltamivir
Dosage (mg) Ritonavir Oseltamivir
Metabolism Ritonavir Oseltamivir

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Zanamivir"
Personal tools